Immune regulation of poly unsaturated fatty acids and free fatty acid receptor 4.

Free fatty acid receptor G-protein coupled receptor immune regulation organ transplantation polyunsaturated fatty acid

Journal

The Journal of nutritional biochemistry
ISSN: 1873-4847
Titre abrégé: J Nutr Biochem
Pays: United States
ID NLM: 9010081

Informations de publication

Date de publication:
02 2023
Historique:
received: 18 12 2021
revised: 24 09 2022
accepted: 10 11 2022
pubmed: 20 11 2022
medline: 11 1 2023
entrez: 19 11 2022
Statut: ppublish

Résumé

Fatty acid metabolism contributes to energy supply and plays an important role in regulating immunity. Free fatty acids (FFAs) bind to free fatty acid receptors (FFARs) on the cell surface and mediate effects through the intra-cellular FFAR signaling pathways. FFAR4, also known as G-protein coupled receptor 120 (GPR120), has been identified as the primary receptor of omega-3 polyunsaturated fatty acids (ω-3 PUFAs). FFAR4 is a promising target for treating metabolic and inflammatory disorders due to its immune regulatory functions and the discovery of highly selective and efficient agonists. This review summarizes the reported immune regulatory functions of ω-3 PUFAs and FFAR4 in immune cells and immune-related diseases. We also speculate possible involvements of ω-3 PUFAs and FFAR4 in other types of inflammatory disorders.

Identifiants

pubmed: 36402250
pii: S0955-2863(22)00290-X
doi: 10.1016/j.jnutbio.2022.109222
pii:
doi:

Substances chimiques

Fatty Acids, Omega-3 0
Fatty Acids, Unsaturated 0
Receptors, G-Protein-Coupled 0
FFAR4 protein, human 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109222

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Maxwell Duah (M)

Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Kexin Zhang (K)

Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Yiwen Liang (Y)

Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Vivian Adiila Ayarick (VA)

Department of Pathophysiology, Institute for Cancer Research, School of Basic Medical Science, Xi'an Jiaotong University, Xi'an, Shanxi, China.

Kailin Xu (K)

Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. Electronic address: lihmd@163.com.

Bin Pan (B)

Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China; Department of Hematology, Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. Electronic address: panbinsam@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH